Switching to DTG/3TC fixed-dose combination (FDC) Is non-inferior to continuing a TAF-based regimen in maintaining virologic suppression through 48 weeks (TANGO Study)
Gorde:
| Egile Nagusiak: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Elsevier
2020-02-01
|
| Saila: | Journal of Infection and Public Health |
| Sarrera elektronikoa: | http://www.sciencedirect.com/science/article/pii/S1876034120301180 |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|